Response to Croteau & Neufeld Editorial: 'Transition considerations for extended half-life factor products'.
Biogen, Cambridge, MA, USA.
S
S
Krishnan
Biogen, Cambridge, MA, USA.
B
B
Buckley
Biogen, Cambridge, MA, USA.
A
A
Brennan
Biogen, Cambridge, MA, USA.
W Y
WY
Wong
D001779:Blood Coagulation Factors / Q000493:pharmacokinetics*; D006801:Humans
D001779:Blood Coagulation Factors